Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Linda M. McManus is active.

Publication


Featured researches published by Linda M. McManus.


Journal of Dental Research | 2003

Persistent Acute Inflammation at the Implant-Abutment Interface:

N. Broggini; Linda M. McManus; Joachim S. Hermann; R.U. Medina; T.W. Oates; Robert K. Schenk; Daniel Buser; James T. Mellonig; David L. Cochran

The inflammatory response adjacent to implants has not been well-investigated and may influence peri-implant tissue levels. The purpose of this study was to assess, histomorphometrically, (1) the timing of abutment connection and (2) the influence of a microgap. Three implant designs were placed in the mandibles of dogs. Two-piece implants were placed at the alveolar crest and abutments connected either at initial surgery (non-submerged) or three months later (submerged). The third implant was one-piece. Adjacent interstitial tissues were analyzed. Both two-piece implants resulted in a peak of inflammatory cells approximately 0.50 mm coronal to the microgap and consisted primarily of neutrophilic polymorphonuclear leukocytes. For one-piece implants, no such peak was observed. Also, significantly greater bone loss was observed for both two-piece implants compared with one-piece implants. In summary, the absence of an implant-abutment interface (microgap) at the bone crest was associated with reduced peri-implant inflammatory cell accumulation and minimal bone loss.


Journal of Dental Research | 2006

Peri-implant Inflammation Defined by the Implant-Abutment Interface

Nina Broggini; Linda M. McManus; Joachim S. Hermann; Raúl Uriel Medina; Robert K. Schenk; Daniel Buser; David L. Cochran

An implant-abutment interface at the alveolar bone crest is associated with sustained peri-implant inflammation; however, whether magnitude of inflammation is proportionally dependent upon interface position remains unknown. This study compared the distribution and density of inflammatory cells surrounding implants with a supracrestal, crestal, or subcrestal implant-abutment interface. All implants developed a similar pattern of peri-implant inflammation: neutrophilic polymorphonuclear leukocytes (neutrophils) maximally accumulated at or immediately coronal to the interface. However, peri-implant neutrophil accrual increased progressively as the implant-abutment interface depth increased, i.e., subcrestal interfaces promoted a significantly greater maximum density of neutrophils than did supracrestal interfaces (10,512 ± 691 vs. 2398 ± 1077 neutrophils/mm2). Moreover, inflammatory cell accumulation below the original bone crest was significantly correlated with bone loss. Thus, the implant-abutment interface dictates the intensity and location of peri-implant inflammatory cell accumulation, a potential contributing component in the extent of implant-associated alveolar bone loss.


BMC Genomics | 2009

Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis

Yongxin Chen; Jonathan Gelfond; Linda M. McManus; Paula K. Shireman

BackgroundMicroRNAs (miRNAs) have critical functions in various biological processes. MiRNA profiling is an important tool for the identification of differentially expressed miRNAs in normal cellular and disease processes. A technical challenge remains for high-throughput miRNA expression analysis as the number of miRNAs continues to increase with in silico prediction and experimental verification. Our study critically evaluated the performance of a novel miRNA expression profiling approach, quantitative RT-PCR array (qPCR-array), compared to miRNA detection with oligonucleotide microchip (microarray).ResultsHigh reproducibility with qPCR-array was demonstrated by comparing replicate results from the same RNA sample. Pre-amplification of the miRNA cDNA improved sensitivity of the qPCR-array and increased the number of detectable miRNAs. Furthermore, the relative expression levels of miRNAs were maintained after pre-amplification. When the performance of qPCR-array and microarrays were compared using different aliquots of the same RNA, a low correlation between the two methods (r = -0.443) indicated considerable variability between the two assay platforms. Higher variation between replicates was observed in miRNAs with low expression in both assays. Finally, a higher false positive rate of differential miRNA expression was observed using the microarray compared to the qPCR-array.ConclusionOur studies demonstrated high reproducibility of TaqMan qPCR-array. Comparison between different reverse transcription reactions and qPCR-arrays performed on different days indicated that reverse transcription reactions did not introduce significant variation in the results. The use of cDNA pre-amplification increased the sensitivity of miRNA detection. Although there was variability associated with pre-amplification in low abundance miRNAs, the latter did not involve any systemic bias in the estimation of miRNA expression. Comparison between microarray and qPCR-array indicated superior sensitivity and specificity of qPCR-array.


Journal of Clinical Investigation | 1981

Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.

Linda M. McManus; Donald J. Hanahan; R. N. Pinckard

Acetyl glyceryl ether phosphorylcholine (AGEPC) induced dose-dependent platelet aggregation and release of [3H]serotonin and platelet factor 4 in citrated human platelet-rich plasma. ADP scavengers or indomethacin prevented irreversible platelet aggregation responses induced by 0.2 microM AGEPC but had no effect upon platelet secretion; prostacyclin inhibited AGEPC-induced aggregation and secretion. EDTA or EGTA inhibited AGEPC-induced aggregation but had no effect on platelet secretion.


Circulation | 1988

Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.

Michael H. Crawford; Frederick L. Grover; W. P. Kolb; C A McMahan; Robert A. O'Rourke; Linda M. McManus; R N Pinckard

Complement depletion with cobra venom factor (CVF) before coronary artery ligation has been previously shown to reduce subsequent ischemic myocardial tissue injury in the baboon; however, whether complement depletion after the initiation of acute myocardial ischemia affords similar myocardial preservation is not known. Both complement depletion with CVF or the administration of certain nonsteroidal anti-inflammatory drugs, including ibuprofen, are thought to decrease myocardial infarct size by reducing polymorphonuclear leukocytic (PMN) infiltration; nevertheless, complement activation also could alter tissue injury by PMN-independent actions. Thus, the relative effects of CVF administered after coronary artery ligation on the subsequent development of myocardial tissue injury were assessed in a baboon myocardial infarction model. The animals were randomized into three treatment groups (n = 6): either CVF (125 units/kg) or saline was given 30 minutes after coronary artery ligation, and ibuprofen (12.5 mg/kg) was administered 30 minutes and 4 hours after ligation. The extent of ischemic myocardial injury was assessed 24 hours later. Relative to saline-treated baboons, both CVF and ibuprofen reduced PMN infiltration (36 +/- 4 vs. 24 +/- 4 and 24 +/- 4 PMN/mm2, respectively; mean +/- SEM) and histological evidence of transmural myocardial infarction (100% vs. 47% and 53%, respectively) in electrocardiographically designated, expected infarct sites. In both saline- and ibuprofen-treated animals, there was extensive localization of C4, C3, and C5 in all infarct sites; in contrast, there was only C4 localization in the CVF-treated baboons. When expected infarct sites were assessed for creatine kinase content as an indicator of tissue injury, there was significantly less epicardial and endocardial creatine kinase depletion in the CVF-treated animals (31.7 +/- 5.6% and 39.3 +/- 4.8%) than in the saline-treated animals (54.1 +/- 5.4% and 59.0 +/- 4.7%; p = 0.012 and 0.011, respectively). The percent creatine kinase depletion in the ibuprofen-treated animals was intermediate between the two other groups. These results suggest that depletion of complement after coronary ligation has beneficial effects in reducing tissue injury that cannot be explained solely on the basis of reducing PMN infiltration into the ischemic myocardium.


Journal of Clinical Investigation | 1980

Complement Localization and Mediation of Ischemic Injury in Baboon Myocardium

R. N. Pinckard; Robert A. O'Rourke; Michael H. Crawford; F. S. Grover; Linda M. McManus; J. J. Ghidoni; S. B. Storrs; M. S. Olson

We sought to determine whether the third component of complement (C3) is localized in ischemic baboon myocardium after coronary artery ligation. Furthermore, we assessed the effects of prior C3 depletion on myocardial necrosis. We studied seven control baboons (group I) and seven C3-depleted (group II) baboons that were killed 24 h after ligation of the anterior descending coronary artery. Multiple tissue samples were obtained from infarct, intermediate, and normal myocardial sites as defined by serial unipolar epicardial ECG mapping. In group I baboons, myocardial creatine kinase content from infarct sites was reduced as compared with normal sites (12.6+/-0.92 [SE] vs. 24.4+/-0.75 IU/mg protein, P < 0.001). The intermediate sites from group I contained more creatine kinase (19.0+/-1.25 IU/mg protein) than infarct sites (P < 0.001), but less (P < 0.025) than normal sites. In group II, intermediate sites showed no significant reduction in creatine kinase from normal sites and there was significantly less creatine kinase depletion in infarct sites when compared with group I animals (33.7+/-4.6 and 51.4+/-1.8% depletion, respectively, P < 0.001). In all seven group I baboons, uniform C3 localization was observed in infarct sites by direct immunofluorescence but appeared in mosaic patterns in intermediate sites. C3 was not demonstrated in any normal sites, nor in any site from group II baboons. Additional studies on baboons killed at earlier times after ligation indicated that C3 was localized focally on swollen myocytes in infarct sites as early as 4 h after coronary ligation. These results strongly implicate the active participation of the complement system of inflammatory proteins in the pathogenesis of myocardial tissue injury following coronary occlusion.


Journal of Leukocyte Biology | 2007

MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration

Paula K. Shireman; Verónica Contreras-Shannon; Oscar Ochoa; Bijal Karia; Joel E. Michalek; Linda M. McManus

We examined the role of MCP‐1, a potent chemotactic and activating factor for macrophages, in perfusion, inflammation, and skeletal muscle regeneration post‐ischemic injury. MCP‐1−/− or C57Bl/6J control mice [wild‐type (WT)] underwent femoral artery excision (FAE). Muscles were collected for histology, assessment of tissue chemokines, and activity measurements of lactate dehydrogenase (LDH) and myeloperoxidase. In MCP‐1−/− mice, restoration of perfusion was delayed, and LDH and fiber size, indicators of muscle regeneration, were decreased. Altered inflammation was observed with increased neutrophil accumulation in MCP‐1−/− versus WT mice at Days 1 and 3 (P≤0.003), whereas fewer macrophages were present in MCP‐1−/− mice at Day 3. As necrotic tissue was removed in WT mice, macrophages decreased (Day 7). In contrast, macrophage accumulation in MCP‐1−/− was increased in association with residual necrotic tissue and impaired muscle regeneration. Consistent with altered inflammation, neutrophil chemotactic factors (keratinocyte‐derived chemokine and macrophage inflammatory protein‐2) were increased at Day 1 post‐FAE. The macrophage chemotactic factor MCP‐5 was increased significantly in WT mice at Day 3 compared with MCP‐1−/− mice. However, at post‐FAE Day 7, MCP‐5 was significantly elevated in MCP‐1−/− mice versus WT mice. Addition of exogenous MCP‐1 did not induce proliferation in murine myoblasts (C2C12 cells) in vitro. MCP‐1 is essential for reperfusion and the successful completion of normal skeletal muscle regeneration after ischemic tissue injury. Impaired muscle regeneration in MCP‐1−/− mice suggests an important role for macrophages and MCP‐1 in tissue reparative processes.


Journal of Leukocyte Biology | 2001

Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia.

Linda M. McManus; Rebecca C. Bloodworth; Thomas J. Prihoda; Janet Blodgett; R. Neal Pinckard

Inexplicable controversies with regard to possible functional defects of neutrophilic polymorphonuclear leukocytes (PMNs) in diabetes persist. The purpose of the present study was to elucidate the relative effectiveness of several PMN agonists in stimulating lysosomal‐enzyme secretion and leukotriene (LT) B4 production by PMNs isolated from diabetic subjects. Formyl‐methionyl‐leucyl‐phenylalanine (fMLP) and platelet‐activating factor (PAF) induced significantly less lysosomal‐enzyme secretion and LTB4 production in diabetic‐subject PMNs than in normal‐subject PMNs. It is surprising that PMNs from these same diabetic subjects responded normally after stimulation with A23187, serum‐opsonized zymosan, or phorbol myristate acetate. The in vitro responsiveness of PMNs stimulated with fMLP or PAF was inversely correlated with indices of in vivo glycemic control (fasting plasma glucose and glycated‐hemoglobin levels). In combination, these results indicate that hyperglycemia is associated with sustained decreases in PMN function but only in response to agonists that initiate stimulus‐response coupling via G‐protein‐coupled receptors. This agonist‐selective reduction in PMN responsiveness may contribute to the compromised host defense associated with sustained hyperglycemia in diabetes.


Journal of Clinical Investigation | 1990

Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.

A. Kukita; C. Chenu; Linda M. McManus; Gregory R. Mundy; G. D. Roodman

Although Pagets disease is the most flagrant example of a primary osteoclast disorder, little is known of osteoclast biology in this disease. In this report we have studied the formation of cells with the osteoclast phenotype in long-term cultures of marrow mononuclear cells derived from patients with Pagets disease, and compared these with similar cells formed in long-term marrow cultures from normal individuals, and with osteoclasts present in pagetic bone. Osteoclasts formed in pagetic marrow cultures resembled osteoclasts present in pagetic bone, but were distinctly different from osteoclasts formed in normal marrow cultures. Osteoclast formation was 10-20-fold greater in pagetic marrow cultures than in normal cultures. The multinucleated cells formed in cultures of pagetic marrow were much larger in size, were hyperresponsive to 1,25(OH)2 vitamin D, had more nuclei per cell, had increased levels of tartrate-resistant acid phosphatase activity and had ultrastructural features which were not seen in multinucleated cells formed from normal marrow mononuclear cells. These pagetic marrow-derived multinucleated cells formed large resorption lacunae on calcified matrices and cross-reacted with monoclonal antibodies which preferentially bind to osteoclasts. The multinucleated cells formed from marrow obtained from uninvolved sites in Pagets patients also displayed these abnormal features.


Biochemical and Biophysical Research Communications | 1981

Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues

Donald J. Hanahan; P.G. Munder; Kiyoshi Satouchi; Linda M. McManus; R. Neal Pinckard

Surprisingly, the sn-1 configuration of 1-0-hexadecyl-2-acetyl-glycerylphosphorylcholine showed significant activity, 3.22 × 10−9 M, when compared to the sn-3 enantiomer, 2.92 × 10−10 M and a racemic mixture with a value of 7.2 × 10−10 M. A methoxy substitution at the C-1 or C-2 position of octadecyl glycerylphosphorylcholine gave a derivative with high biological activity for stimulating serotonin release from rabbit platelets. A 1-0-dodecyl-2-methoxy analogue showed very low activity; also, a comparable series of 0-benzyl derivatives were inactive. Examination of 1-0-hexadecyl, 1-0-octadecyl- or 1-0-dodecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine showed that the hexadecyl compound had three times the biological activity of the octadecyl and five times that of the dodecyl.

Collaboration


Dive into the Linda M. McManus's collaboration.

Top Co-Authors

Avatar

Paula K. Shireman

University of Texas System

View shared research outputs
Top Co-Authors

Avatar

Donald J. Hanahan

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Joel E. Michalek

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

R. Neal Pinckard

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Oscar Ochoa

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Thomas J. Prihoda

University of Texas System

View shared research outputs
Top Co-Authors

Avatar

Beth Goins

University of Texas System

View shared research outputs
Top Co-Authors

Avatar

Dongxu Sun

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Donna S. Woodard

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

G. D. Roodman

University of Texas Health Science Center at San Antonio

View shared research outputs
Researchain Logo
Decentralizing Knowledge